Key Takeaways
- • Vontier Corporation (VNT) closed at $28.03 on May 15, 2026, down $0.69 (-2.40%) from the previous close of $28.72, reflecting continued volatility in the stock despite institutional interest.
- • Market capitalization stands at approximately $3.95–4.24 billion with a trailing P/E ratio of 9.90–10.63, indicating a relatively compressed valuation relative to historical analyst targets.
- • Citigroup maintained a Buy rating on May 8, 2026, but lowered its price target from $50 to $44, signaling caution despite bullish sentiment; analyst consensus averages $47.36 across 11 analysts, ranging from $40 to $53.
- • The company generated trailing twelve-month revenue of $3.09 billion with net income of $412.5 million (diluted EPS of $2.83) and demonstrates strong profitability metrics including a 13.37% profit margin and 34.78% return on equity.
- • The 52-week trading range of $27.78–$48.20 illustrates significant share price volatility; the stock trades below its earlier 2026 highs, with a beta of 1.24 indicating above-market sensitivity to broader equity movements.
Summary
Vontier Corporation's stock performance reflects a disconnect between operational fundamentals and share price trajectory. As of May 15, 2026, VNT traded at $28.03, representing a 2.40% single-day decline and positioning shares near the lower end of their 52-week range ($27.78–$48.20). This volatility occurs despite the company's solid profitability metrics: trailing twelve-month revenue of $3.09 billion, net income of $412.5 million, and a diluted EPS of $2.83.
The valuation picture presents a mixed narrative for institutional investors. Trading at a trailing P/E of approximately 10.63 and forward P/E of 8.73, Vontier appears to trade at a discount relative to analyst consensus. Citigroup, maintaining a Buy rating as of May 8, 2026, adjusted its price target downward from $50 to $44, tempering optimism while preserving bullish coverage. Across 11 analysts tracked, consensus price targets average $47.36, with a range of $40–$53, suggesting meaningful upside potential at current levels—though downside scenarios remain embedded in analyst price ranges.
The company's balance sheet supports operational stability, with total cash of $233.8 million and a debt-to-equity ratio of 1.53 (as of the most recent quarter). Return on equity of 34.78% and return on assets of 8.46% underscore capital efficiency. However, modest dividend yield (0.36% based on a forward dividend of $0.10) and a PEG ratio of 0.85 suggest limited growth expectations relative to earnings multiples.
Analyst positioning shows 38% of research coverage recommending Strong Buy and 38% recommending Buy, with 13% holding and 13% recommending sales—indicating no consensus weakness but material skepticism among a minority of analysts. The stock's beta of 1.24 indicates heightened sensitivity to broader market movements, which may explain recent underperformance during periods of equity market volatility. The divergence between consensus price targets ($47.36) and current trading levels ($28.03) suggests either that the market has repriced risk materially higher than analysts anticipate, or that analyst targets have not yet adjusted to new market conditions.
The valuation picture presents a mixed narrative for institutional investors. Trading at a trailing P/E of approximately 10.63 and forward P/E of 8.73, Vontier appears to trade at a discount relative to analyst consensus. Citigroup, maintaining a Buy rating as of May 8, 2026, adjusted its price target downward from $50 to $44, tempering optimism while preserving bullish coverage. Across 11 analysts tracked, consensus price targets average $47.36, with a range of $40–$53, suggesting meaningful upside potential at current levels—though downside scenarios remain embedded in analyst price ranges.
The company's balance sheet supports operational stability, with total cash of $233.8 million and a debt-to-equity ratio of 1.53 (as of the most recent quarter). Return on equity of 34.78% and return on assets of 8.46% underscore capital efficiency. However, modest dividend yield (0.36% based on a forward dividend of $0.10) and a PEG ratio of 0.85 suggest limited growth expectations relative to earnings multiples.
Analyst positioning shows 38% of research coverage recommending Strong Buy and 38% recommending Buy, with 13% holding and 13% recommending sales—indicating no consensus weakness but material skepticism among a minority of analysts. The stock's beta of 1.24 indicates heightened sensitivity to broader market movements, which may explain recent underperformance during periods of equity market volatility. The divergence between consensus price targets ($47.36) and current trading levels ($28.03) suggests either that the market has repriced risk materially higher than analysts anticipate, or that analyst targets have not yet adjusted to new market conditions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.